Open Bionics
Open Bionics develops affordable, lightweight 3D printed bionic arms for upper limb amputees, including children.
- CEO / Founder
- Joel Gibbard
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- $18.8M
- Latest Round
- Debt
- Key Investors
- Foresight Williams Technology, Ananda Impact Ventures, Downing Ventures, SCVC, Innovate UK, NHS England (grants), Crowdcube, NatWest
Technology & Products
Key Products
Hero Arm: The world's first medically certified 3D printed bionic arm, available through the NHS for free.
Technological Advantage
3D printing enables custom fit and personalized designs at fraction of traditional prosthetic costs
Differentiation
Value Proposition
Hero Arm is the worlds first medically certified 3D printed bionic arm, available through the NHS for free.
How They Differentiate
Affordable price point, customizable aesthetics, designed for children and adults, NHS coverage
Market & Competition
Target Customers
Upper limb amputees, NHS hospitals, prosthetic clinics, children and adults
Industry Verticals
Medical Devices, Prosthetics, Healthcare
Competitors
Össur, Ottobock, Psyonic, Limbitless Solutions
Growth & Milestones
Growth Metrics
Over 600 Hero Arms delivered globally; Available through NHS in UK; Health insurance reimbursed in USA; Expanded to multiple countries
Major Milestones
2014: Founded by Joel Gibbard and Samantha Payne in Bristol; 2016: Seed funding raised; 2017: NHS England clinical trial partnership; 2018: Hero Arm launch, Disney/Marvel licensing agreements; 2019: $5.9M Series A led by Foresight Williams; 2020: MBE awards for both co-founders; 2022: Crowdcube funding round; 2024: Hero RGD and Hero PRO product launches; Available through NHS
Notable Customers
Walter Reed Medical Center, Sahlgrenska University Hospital